Compile Data Set for Download or QSAR
Report error Found 44 Enz. Inhib. hit(s) with all data for entry = 50039541
TargetP2X purinoceptor 3(Human)
Astrazeneca

Curated by ChEMBL
LigandPNGBDBM50379718(CHEMBL2011127)
Affinity DataIC50: 22nMAssay Description:Antagonist activity at human P2X3 receptor expressed in RLE cells assessed as inhibition of (alpha,beta)me-ATP-induced intracellular calcium level by...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2013
Entry Details Article
PubMed
TargetP2X purinoceptor 3(Human)
Astrazeneca

Curated by ChEMBL
LigandPNGBDBM50379716(CHEMBL2011125)
Affinity DataIC50: 24nMAssay Description:Antagonist activity at human P2X3 receptor expressed in RLE cells assessed as inhibition of (alpha,beta)me-ATP-induced intracellular calcium level by...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2013
Entry Details Article
PubMed
TargetP2X purinoceptor 3(Human)
Astrazeneca

Curated by ChEMBL
LigandPNGBDBM50379717(CHEMBL2011126)
Affinity DataIC50: 24nMAssay Description:Antagonist activity at human P2X3 receptor expressed in RLE cells assessed as inhibition of (alpha,beta)me-ATP-induced intracellular calcium level by...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2013
Entry Details Article
PubMed
TargetP2X purinoceptor 3(Human)
Astrazeneca

Curated by ChEMBL
LigandPNGBDBM50379714(CHEMBL2011123)
Affinity DataIC50: 38nMAssay Description:Antagonist activity at human P2X3 receptor expressed in RLE cells assessed as inhibition of (alpha,beta)me-ATP-induced intracellular calcium level by...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2013
Entry Details Article
PubMed
TargetP2X purinoceptor 3(Human)
Astrazeneca

Curated by ChEMBL
LigandPNGBDBM50379707(CHEMBL2011112)
Affinity DataIC50: 61nMAssay Description:Antagonist activity at human P2X3 receptor expressed in RLE cells assessed as inhibition of (alpha,beta)me-ATP-induced intracellular calcium level by...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2013
Entry Details Article
PubMed
TargetP2X purinoceptor 3(Human)
Astrazeneca

Curated by ChEMBL
LigandPNGBDBM50379719(CHEMBL2011118)
Affinity DataIC50: 64nMAssay Description:Antagonist activity at human P2X3 receptor expressed in RLE cells assessed as inhibition of (alpha,beta)me-ATP-induced intracellular calcium level by...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2013
Entry Details Article
PubMed
TargetP2X purinoceptor 3(Human)
Astrazeneca

Curated by ChEMBL
LigandPNGBDBM50379736(CHEMBL2011116)
Affinity DataIC50: 67nMAssay Description:Antagonist activity at human P2X3 receptor expressed in RLE cells assessed as inhibition of (alpha,beta)me-ATP-induced intracellular calcium level by...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2013
Entry Details Article
PubMed
TargetP2X purinoceptor 3(Human)
Astrazeneca

Curated by ChEMBL
LigandPNGBDBM50379711(CHEMBL2011120)
Affinity DataIC50: 69nMAssay Description:Antagonist activity at human P2X3 receptor expressed in RLE cells assessed as inhibition of (alpha,beta)me-ATP-induced intracellular calcium level by...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2013
Entry Details Article
PubMed
TargetP2X purinoceptor 3(Human)
Astrazeneca

Curated by ChEMBL
LigandPNGBDBM50379713(CHEMBL2011122)
Affinity DataIC50: 115nMAssay Description:Antagonist activity at human P2X3 receptor expressed in RLE cells assessed as inhibition of (alpha,beta)me-ATP-induced intracellular calcium level by...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2013
Entry Details Article
PubMed
TargetP2X purinoceptor 3(Human)
Astrazeneca

Curated by ChEMBL
LigandPNGBDBM50379712(CHEMBL2011121)
Affinity DataIC50: 212nMAssay Description:Antagonist activity at human P2X3 receptor expressed in RLE cells assessed as inhibition of (alpha,beta)me-ATP-induced intracellular calcium level by...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2013
Entry Details Article
PubMed
TargetP2X purinoceptor 3(Human)
Astrazeneca

Curated by ChEMBL
LigandPNGBDBM50379708(CHEMBL2010931)
Affinity DataIC50: 255nMAssay Description:Antagonist activity at human P2X3 receptor expressed in RLE cells assessed as inhibition of (alpha,beta)me-ATP-induced intracellular calcium level by...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2013
Entry Details Article
PubMed
TargetP2X purinoceptor 3(Human)
Astrazeneca

Curated by ChEMBL
LigandPNGBDBM50379734(CHEMBL2011111)
Affinity DataIC50: 262nMAssay Description:Antagonist activity at human P2X3 receptor expressed in RLE cells assessed as inhibition of (alpha,beta)me-ATP-induced intracellular calcium level by...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2013
Entry Details Article
PubMed
TargetP2X purinoceptor 3(Human)
Astrazeneca

Curated by ChEMBL
LigandPNGBDBM50379724(CHEMBL2010933)
Affinity DataIC50: 268nMAssay Description:Antagonist activity at human P2X3 receptor expressed in RLE cells assessed as inhibition of (alpha,beta)me-ATP-induced intracellular calcium level by...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2013
Entry Details Article
PubMed
TargetP2X purinoceptor 3(Rat)
Astrazeneca

Curated by ChEMBL
LigandPNGBDBM50379707(CHEMBL2011112)
Affinity DataIC50: 280nMAssay Description:Antagonist activity at rat P2X3 receptorMore data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2013
Entry Details Article
PubMed
TargetP2X purinoceptor 3(Human)
Astrazeneca

Curated by ChEMBL
LigandPNGBDBM50379706(CHEMBL2011115)
Affinity DataIC50: 324nMAssay Description:Antagonist activity at human P2X3 receptor expressed in RLE cells assessed as inhibition of (alpha,beta)me-ATP-induced intracellular calcium level by...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2013
Entry Details Article
PubMed
TargetP2X purinoceptor 3(Human)
Astrazeneca

Curated by ChEMBL
LigandPNGBDBM50379722(CHEMBL2010930)
Affinity DataIC50: 327nMAssay Description:Antagonist activity at human P2X3 receptor expressed in RLE cells assessed as inhibition of (alpha,beta)me-ATP-induced intracellular calcium level by...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2013
Entry Details Article
PubMed
TargetP2X purinoceptor 3(Human)
Astrazeneca

Curated by ChEMBL
LigandPNGBDBM50379725(CHEMBL2011102)
Affinity DataIC50: 398nMAssay Description:Antagonist activity at human P2X3 receptor expressed in RLE cells assessed as inhibition of (alpha,beta)me-ATP-induced intracellular calcium level by...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2013
Entry Details Article
PubMed
TargetP2X purinoceptor 3(Human)
Astrazeneca

Curated by ChEMBL
LigandPNGBDBM50379726(CHEMBL2011103)
Affinity DataIC50: 440nMAssay Description:Antagonist activity at human P2X3 receptor expressed in RLE cells assessed as inhibition of (alpha,beta)me-ATP-induced intracellular calcium level by...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2013
Entry Details Article
PubMed
TargetP2X purinoceptor 3(Human)
Astrazeneca

Curated by ChEMBL
LigandPNGBDBM50379732(CHEMBL2011109)
Affinity DataIC50: 441nMAssay Description:Antagonist activity at human P2X3 receptor expressed in RLE cells assessed as inhibition of (alpha,beta)me-ATP-induced intracellular calcium level by...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2013
Entry Details Article
PubMed
TargetP2X purinoceptor 3(Human)
Astrazeneca

Curated by ChEMBL
LigandPNGBDBM50379715(CHEMBL2011124)
Affinity DataIC50: 521nMAssay Description:Antagonist activity at human P2X3 receptor expressed in RLE cells assessed as inhibition of (alpha,beta)me-ATP-induced intracellular calcium level by...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2013
Entry Details Article
PubMed
TargetP2X purinoceptor 3(Human)
Astrazeneca

Curated by ChEMBL
LigandPNGBDBM50379709(CHEMBL2011117)
Affinity DataIC50: 613nMAssay Description:Antagonist activity at human P2X3 receptor expressed in RLE cells assessed as inhibition of (alpha,beta)me-ATP-induced intracellular calcium level by...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2013
Entry Details Article
PubMed
TargetP2X purinoceptor 3(Human)
Astrazeneca

Curated by ChEMBL
LigandPNGBDBM50379721(CHEMBL2010929)
Affinity DataIC50: 618nMAssay Description:Antagonist activity at human P2X3 receptor expressed in RLE cells assessed as inhibition of (alpha,beta)me-ATP-induced intracellular calcium level by...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2013
Entry Details Article
PubMed
TargetP2X purinoceptor 3(Human)
Astrazeneca

Curated by ChEMBL
LigandPNGBDBM50379735(CHEMBL2011114)
Affinity DataIC50: 1.27E+3nMAssay Description:Antagonist activity at human P2X3 receptor expressed in RLE cells assessed as inhibition of (alpha,beta)me-ATP-induced intracellular calcium level by...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2013
Entry Details Article
PubMed
TargetP2X purinoceptor 3(Human)
Astrazeneca

Curated by ChEMBL
LigandPNGBDBM50379731(CHEMBL2011108)
Affinity DataIC50: 1.31E+3nMAssay Description:Antagonist activity at human P2X3 receptor expressed in RLE cells assessed as inhibition of (alpha,beta)me-ATP-induced intracellular calcium level by...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2013
Entry Details Article
PubMed
TargetP2X purinoceptor 3(Human)
Astrazeneca

Curated by ChEMBL
LigandPNGBDBM50379720(CHEMBL2010928)
Affinity DataIC50: 1.36E+3nMAssay Description:Antagonist activity at human P2X3 receptor expressed in RLE cells assessed as inhibition of (alpha,beta)me-ATP-induced intracellular calcium level by...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2013
Entry Details Article
PubMed
TargetP2X purinoceptor 3(Human)
Astrazeneca

Curated by ChEMBL
LigandPNGBDBM50379730(CHEMBL2011107)
Affinity DataIC50: 1.67E+3nMAssay Description:Antagonist activity at human P2X3 receptor expressed in RLE cells assessed as inhibition of (alpha,beta)me-ATP-induced intracellular calcium level by...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2013
Entry Details Article
PubMed
TargetP2X purinoceptor 3(Human)
Astrazeneca

Curated by ChEMBL
LigandPNGBDBM50379723(CHEMBL2010932)
Affinity DataIC50: 1.95E+3nMAssay Description:Antagonist activity at human P2X3 receptor expressed in RLE cells assessed as inhibition of (alpha,beta)me-ATP-induced intracellular calcium level by...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2013
Entry Details Article
PubMed
TargetCytochrome P450 2C9(Human)
Astrazeneca

Curated by ChEMBL
LigandPNGBDBM50379707(CHEMBL2011112)
Affinity DataIC50: 2.00E+3nMAssay Description:Inhibition of recombinant CYP2C9More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2013
Entry Details Article
PubMed
TargetP2X purinoceptor 3(Human)
Astrazeneca

Curated by ChEMBL
LigandPNGBDBM50379733(CHEMBL2011110)
Affinity DataIC50: 2.06E+3nMAssay Description:Antagonist activity at human P2X3 receptor expressed in RLE cells assessed as inhibition of (alpha,beta)me-ATP-induced intracellular calcium level by...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2013
Entry Details Article
PubMed
TargetCytochrome P450 2C9(Human)
Astrazeneca

Curated by ChEMBL
LigandPNGBDBM50379706(CHEMBL2011115)
Affinity DataIC50: 2.40E+3nMAssay Description:Inhibition of recombinant CYP2C9More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2013
Entry Details Article
PubMed
TargetCytochrome P450 2C9(Human)
Astrazeneca

Curated by ChEMBL
LigandPNGBDBM50379710(CHEMBL2011119)
Affinity DataIC50: 2.40E+3nMAssay Description:Inhibition of recombinant CYP2C9More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2013
Entry Details Article
PubMed
TargetCytochrome P450 2C9(Human)
Astrazeneca

Curated by ChEMBL
LigandPNGBDBM50379705(CHEMBL2011113)
Affinity DataIC50: 2.40E+3nMAssay Description:Inhibition of recombinant CYP2C9More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2013
Entry Details Article
PubMed
TargetP2X purinoceptor 3(Human)
Astrazeneca

Curated by ChEMBL
LigandPNGBDBM50379710(CHEMBL2011119)
Affinity DataIC50: 2.52E+3nMAssay Description:Antagonist activity at human P2X3 receptor expressed in RLE cells assessed as inhibition of (alpha,beta)me-ATP-induced intracellular calcium level by...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2013
Entry Details Article
PubMed
TargetP2X purinoceptor 3(Human)
Astrazeneca

Curated by ChEMBL
LigandPNGBDBM50379705(CHEMBL2011113)
Affinity DataIC50: 4.21E+3nMAssay Description:Antagonist activity at human P2X3 receptor expressed in RLE cells assessed as inhibition of (alpha,beta)me-ATP-induced intracellular calcium level by...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2013
Entry Details Article
PubMed
TargetP2X purinoceptor 3(Human)
Astrazeneca

Curated by ChEMBL
LigandPNGBDBM50379727(CHEMBL2011104)
Affinity DataIC50: 5.69E+3nMAssay Description:Antagonist activity at human P2X3 receptor expressed in RLE cells assessed as inhibition of (alpha,beta)me-ATP-induced intracellular calcium level by...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2013
Entry Details Article
PubMed
TargetCytochrome P450 2C9(Human)
Astrazeneca

Curated by ChEMBL
LigandPNGBDBM50379718(CHEMBL2011127)
Affinity DataIC50: 7.00E+3nMAssay Description:Inhibition of recombinant CYP2C9More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2013
Entry Details Article
PubMed
TargetCytochrome P450 2C9(Human)
Astrazeneca

Curated by ChEMBL
LigandPNGBDBM50379717(CHEMBL2011126)
Affinity DataIC50: 7.00E+3nMAssay Description:Inhibition of recombinant CYP2C9More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2013
Entry Details Article
PubMed
TargetCytochrome P450 2C9(Human)
Astrazeneca

Curated by ChEMBL
LigandPNGBDBM50379719(CHEMBL2011118)
Affinity DataIC50: 7.30E+3nMAssay Description:Inhibition of recombinant CYP2C9More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2013
Entry Details Article
PubMed
TargetCytochrome P450 2C9(Human)
Astrazeneca

Curated by ChEMBL
LigandPNGBDBM50379711(CHEMBL2011120)
Affinity DataIC50: 1.00E+4nMAssay Description:Inhibition of recombinant CYP2C9More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2013
Entry Details Article
PubMed
TargetCytochrome P450 2C9(Human)
Astrazeneca

Curated by ChEMBL
LigandPNGBDBM50379714(CHEMBL2011123)
Affinity DataIC50: 1.10E+4nMAssay Description:Inhibition of recombinant CYP2C9More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2013
Entry Details Article
PubMed
TargetP2X purinoceptor 3(Human)
Astrazeneca

Curated by ChEMBL
LigandPNGBDBM50379729(CHEMBL2011106)
Affinity DataIC50: 1.40E+4nMAssay Description:Antagonist activity at human P2X3 receptor expressed in RLE cells assessed as inhibition of (alpha,beta)me-ATP-induced intracellular calcium level by...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2013
Entry Details Article
PubMed
TargetCytochrome P450 2C9(Human)
Astrazeneca

Curated by ChEMBL
LigandPNGBDBM50379713(CHEMBL2011122)
Affinity DataIC50: 1.40E+4nMAssay Description:Inhibition of recombinant CYP2C9More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2013
Entry Details Article
PubMed
TargetCytochrome P450 2C9(Human)
Astrazeneca

Curated by ChEMBL
LigandPNGBDBM50379716(CHEMBL2011125)
Affinity DataIC50: 1.60E+4nMAssay Description:Inhibition of recombinant CYP2C9More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2013
Entry Details Article
PubMed
TargetP2X purinoceptor 3(Human)
Astrazeneca

Curated by ChEMBL
LigandPNGBDBM50379728(CHEMBL2011105)
Affinity DataIC50: 3.00E+4nMAssay Description:Antagonist activity at human P2X3 receptor expressed in RLE cells assessed as inhibition of (alpha,beta)me-ATP-induced intracellular calcium level by...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/7/2013
Entry Details Article
PubMed